Controlling the Cost of Social Security.

ILR Review ◽  
1985 ◽  
Vol 39 (1) ◽  
pp. 146
Author(s):  
Lawrence H. Thompson ◽  
Colin D. Campbell
Keyword(s):  
2001 ◽  
Vol 3 (1) ◽  
pp. 7-24
Author(s):  
Herwig Verschueren

This article seeks to provide a clearer picture of the role of methods for funding social security benefits in EC Coordination Regulation 1408/71. In past literature and in the case law surrounding Regulation 1408/71, this role has seldom been mentioned. However, this is changing in light of increasing numbers of questions emerging at both the policy-making level and at the level of Court of Justice proceedings. The first part of this paper deals with the role of different methods of financing social security in determining the material scope of the coordination regulation and the question of whether the method of financing certain benefits has a bearing on this material scope. The second part deals with the existing link within the coordination context between paying or having paid contributions and entitlement to benefits. I discuss, inter alia, the extent to which benefit levels are determined by the same legislation as that which determines contribution levels. I examine the extent to which Member States collecting contributions are also responsible for bearing the cost of the corresponding benefits and the extent to which a person who is paying or has paid contributions is entitled to benefits corresponding to those contributions. In light of this examination of the facts as they stand, I endeavour to consider possible alternatives, including the desirability of having a more direct link within the coordination context between payment of contributions and entitlement to benefits.


2019 ◽  
Vol 118 ◽  
pp. 101-125 ◽  
Author(s):  
Frank N. Caliendo ◽  
Aspen Gorry ◽  
Sita Slavov

1984 ◽  
Vol 51 (2) ◽  
pp. 638
Author(s):  
John A. Turner ◽  
Colin D. Campbell
Keyword(s):  

2014 ◽  
Vol 9 (1-2) ◽  
Author(s):  
Noemi Peña-Miguel ◽  
J Iñaki De La Peña Esteban ◽  
Ana Fernandez-Sainz

AbstractThe Social Security System in Spain is significantly broader and more complex than in other EU countries. One of its problems is that it was not created as a single whole. Instead of this, there are different kinds of social assistance service depending on the region, so there is a real need to reduce the complexity of these schemes and homogenise the benefits paid out in a general basic social benefit. In this paper we propose a new approach to universal basic protection benefit (called Basic Social Benefit) as a way of unifying and rationalising the different grants and economic aids currently available in Spain in order to cover the basic needs of all citizens. This is the first study made in Spain in calculating the lump sum of a basic social benefit for the whole population. For this, we use Quantile Regression (QR) to calculate the principal variables that explain the minimum vital expenditures of Spanish citizens. We also show the total financial cost of this measure for Spain in 2010 and a projection of the cost for the next 12 years.


1991 ◽  
Vol 15 (3) ◽  
pp. 337-362 ◽  
Author(s):  
Brian Gratton ◽  
Frances M. Rotondo

In his 1911 film What Shall We Do with Our Old? D.W. Griffith dramatized the belief that urban, industrial America had no place for the elderly. Fired for being too slow at his work, an impoverished old man cannot buy food or medicine for his wife, who languishes in their drab, one-room apartment. Justice Benjamin Cardozo told a similar tale in upholding the constitutionality of the Social Security Act (Helvering v. Davis, 301 U.S. 619 [1937]): “The number of [aged] unable to take care of themselves is growing at a threatening pace. More and more our population is becoming urban and industrial instead of rural and agricultural.” Cardozo relied on studies by the U.S. Social Security Board (1937: 3), which found that “the major part of the industrial population . . . earns scarcely enough to provide for its existence. Savings are small and generally cover little more than the cost of burial insurance.” As a result, “industrial workers in [urban] areas . . . reach old age with few resources” (ibid.: 33).


1943 ◽  
Vol 37 (2) ◽  
pp. 314-319
Author(s):  
W. Hardy Wickwar

The Beveridge, Scott, and Uthwatt reports are all concerned with the widening framework of governmental action within which our free enterprise system operates. None of them is revolutionary. The Scott report has even been called reactionary. The Beveridge and Uthwatt reports are based on a generation of practical experience. In their attempt to infuse a few clear principles into future policy, these two great reports, in their different ways, point towards greater order and system, the smoothing away of anomalies, the filling in of gaps. Procedures which have served certain categories of people or certain localities, they attempt to make universally and equally available to all people or to all localities. They mark a decisive step in the passage from the fragmentariness that is inseparable from experiment to the universality that is characteristic of good government.Sir William Beveridge's plan for social security is nothing less than an attempt to abolish want by redistributing income. He assumes that society has somehow to pay the cost of privation in any case, and therefore might as well do so consciously and deliberately through the instrumentality of government.


2020 ◽  
Vol 10 (3-s) ◽  
pp. 234-238
Author(s):  
Gustavo H. Marin ◽  
Lupe Marin ◽  
Daniel Agüero ◽  
Mariana Pagnotta ◽  
Gina Marin ◽  
...  

The majority of new drugs that are register at Health Global Market are not considered real innovations and due to their chemical structure similarity of reference’s group drug, they are known as “me-too”. These “me too” drugs has no additional therapeutic benefits but greatly increasing treatment´s. PURPOSE: To demonstrate the economic impact in Social Security budget by covering “me too” medicines. METHODS: An epidemiological-descriptive-analytical study was performed in order to analyze the burden of anti-hypertensive prescription from patients under coverage by Buenos Aires State Social Security. Two types of medicines were compared: “pioneer” or “me-too”. Variables considered were: type of drug, class or therapeutical group of medicines, global costs, burden for social security and for patients. RESULTS: From 185865 patients that received medication; in 121748 of the cases the strategy was monotherapy while 64117 received at least two or more medicines. 189714 were reference drugs while 64393 of them were considered “me-too”. In average, “me-too” drugs were 41.23% more expensive than classical treatment. The percentage covered by IOMA varies according to the medicines (between 45 to 51%) and patients must complete the amount of money remaining from their pockets. Paradoxically, the percentage covered by IOMA some “me-too” were greater than the percentage paid for most classic medications of each group. CONCLUSIONS: By only choosing the drug of reference, with proven effectiveness, from each therapeutical group, the State Social Security could cover 100% of the cost of all anti-hypertensive treatment and all patients even saving almost 2 million dollars per year. Keywords: Health, Policies, Medicines, Me too, Economical Burden, Coverage, anti-hypertensive


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Frédéric Bizard ◽  
Thierry Boudemaghe ◽  
Laurent Delaunay ◽  
Lucas Léger ◽  
Karem Slim

Abstract Background Study of the medico economic impact of enhanced rehabilitation after surgery (ERAS), by comparing the cost of patient care with or without ERAS, both from the point of view of the hospitals and the Social Security Health Insurance Program. Methods Retrospective longitudinal study on matched data from March 1, 2019 to December 31, 2019. The data are extracted from the French prospective payment system. We studied 12 of the most commonly performed in ERAS business segments. The primary outcome was the reduction of the average length of hospital stay and its implications on production costs and excess capacity. We also studied the impact on hospital incomes and Social Security Insurance Program expenses. The potential gain in hospital days was computed by comparing the length of stay of ERAS and non-ERAS cases. The cost reduction was estimated using the mean number of avoidable days of hospitalization, and the mean cost of the stays obtained from the national cost study. Finally, we studied an approximation of the additional expense for the Social Security Health Insurance Program on costs standardized by applying public sector rates. Results The average length of stay reduction attributed to ERAS is 1.45 (CI 95% 1.42 to 1.48) day per stay, translating to a cost reduction for the hospitals of € 1060 (CI 95% 995 to 1125) per patient and a total of €65 million (CI 95% 61 to 69). At the same time, the additional expenses for the Social Security Insurance Program can conservatively be approximated to € 1.6 million, breaking into a € 2.2 million increase partially compensated by cost savings of € 0.6 million over subsequent stays for complications. Overall, for each percent of additional ERAS activity over the scope of the study, the marginal cost reduction for the hospitals can be estimated to € 1.8 million (CI 95% 1.7 million to 2.0 million). Conclusions Associated with previously known clinical benefits for the patients, these convincing results in terms of economic gain strongly support expanding the adoption of ERAS.


Sign in / Sign up

Export Citation Format

Share Document